Key Takeaways
- • Benchmark raised Intel's price target to $57 from $50 while maintaining a Buy rating, representing 5% upside from the stock's $54.32 trading price as of the report date.
- • Intel's Q4 2025 results exceeded expectations with revenue of $13.674 billion (beating forecasts by $236 million) and earnings per share of $0.15 (beating consensus by $0.07), driven by AI chip momentum and strong server CPU demand.
- • Despite strong quarterly performance, Intel shares declined as much as 12% in after-hours trading due to disappointing Q1 guidance, which Benchmark analyst Cody Acree characterized as "well deserved profit taking" following a 150% gain over the trailing twelve months.
- • Wall Street remains divided on Intel's outlook: Northland maintains Outperform with a $54 target, JPMorgan maintains Underweight at $35, Needham maintains Hold citing supply constraints, and Rosenblatt maintains Sell at $30, reflecting divergent views on the company's foundry strategy and supply dynamics.
- • Intel's supply constraints are expected to ease in Q2 according to JPMorgan, positioning the company to potentially capitalize on elevated server CPU demand driven by AI infrastructure buildout.
Summary
Benchmark raised its price target on Intel to $57 from $50 while maintaining its Buy rating, reflecting confidence in the chipmaker's AI-driven momentum despite near-term headwinds. The new target implies approximately 5% upside from Intel's trading price of $54.32, positioning the stock just 0.99% below its 52-week high of $54.60.
The price target increase follows Intel's fourth-quarter 2025 financial results, which substantially exceeded market expectations. The company reported revenue of $13.674 billion, surpassing analyst forecasts by $236 million, and delivered earnings per share of $0.15, beating consensus estimates by $0.07. These results underscore strong demand for Intel's AI-related server chips, validating the company's strategic focus on artificial intelligence infrastructure.
However, the market's reaction revealed investor caution regarding forward momentum. Intel shares declined as much as 12% in after-hours trading following the earnings announcement, a decline that Benchmark analyst Cody Acree attributed to disappointing first-quarter guidance. Acree characterized the sharp pullback as "well deserved profit taking," noting that Intel shares had appreciated approximately 150% over the trailing twelve months and nearly 50% since early January 2026, creating natural profit-taking pressure.
Wall Street sentiment remains mixed on Intel's medium-term trajectory. While Benchmark and Northland (which raised its target to $54 with an Outperform rating) project upside, other major institutions maintain skepticism. JPMorgan increased its price target to $35 while keeping an Underweight rating, citing supply constraints that management expects to ease in the second quarter. Needham reiterated a Hold rating, also citing supply constraints as a near-term constraint. Rosenblatt Securities maintained a Sell rating at $30, though it raised that target based on potential announcements regarding external foundry customers. Cantor Fitzgerald reiterated a Neutral rating at $45, expressing surprise at the magnitude of Intel's year-to-date stock appreciation.
The consensus analyst price target across 41 analysts sits at approximately $48.72, with a high estimate of $76 and a low of $20.40, reflecting the substantial disagreement among investment professionals about Intel's path forward and the sustainability of its AI-driven recovery.
The price target increase follows Intel's fourth-quarter 2025 financial results, which substantially exceeded market expectations. The company reported revenue of $13.674 billion, surpassing analyst forecasts by $236 million, and delivered earnings per share of $0.15, beating consensus estimates by $0.07. These results underscore strong demand for Intel's AI-related server chips, validating the company's strategic focus on artificial intelligence infrastructure.
However, the market's reaction revealed investor caution regarding forward momentum. Intel shares declined as much as 12% in after-hours trading following the earnings announcement, a decline that Benchmark analyst Cody Acree attributed to disappointing first-quarter guidance. Acree characterized the sharp pullback as "well deserved profit taking," noting that Intel shares had appreciated approximately 150% over the trailing twelve months and nearly 50% since early January 2026, creating natural profit-taking pressure.
Wall Street sentiment remains mixed on Intel's medium-term trajectory. While Benchmark and Northland (which raised its target to $54 with an Outperform rating) project upside, other major institutions maintain skepticism. JPMorgan increased its price target to $35 while keeping an Underweight rating, citing supply constraints that management expects to ease in the second quarter. Needham reiterated a Hold rating, also citing supply constraints as a near-term constraint. Rosenblatt Securities maintained a Sell rating at $30, though it raised that target based on potential announcements regarding external foundry customers. Cantor Fitzgerald reiterated a Neutral rating at $45, expressing surprise at the magnitude of Intel's year-to-date stock appreciation.
The consensus analyst price target across 41 analysts sits at approximately $48.72, with a high estimate of $76 and a low of $20.40, reflecting the substantial disagreement among investment professionals about Intel's path forward and the sustainability of its AI-driven recovery.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.